バージニアにおける濾胞性リンパ腫の臨床試験
バージニア内の拠点で、濾胞性リンパ腫に関する9件の研究が参加者を募集しています。
バージニア内の都市
公式研究テキスト（英語）
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Virginia Commonwealth University Massey Cancer Center, Richmond
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05006716A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- Research Site, Fairfax
- Research Site, Richmond
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/21更新 · NCT06549595Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Virginia Cancer Specialists, Fairfax
- Virginia Oncology Associates, Norfolk
- Blue Ridge Cancer Center, Wytheville
被験者募集中第3相
12歳〜100歳 · 全性別 · 2026/09/11更新 · NCT06784752A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- University of Virginia, Charlottesville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06091254SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- UVA Health, Emily Couric Clinical Cancer Cente, Charlottesville
- Inova Schar Cancer Institute, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519A Study of ARC-02 in B-cell NHL
- Massey Cancer Center, Richmond
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Virginia Oncology Associates, Norfolk
- Virginia Commonwealth University-Massey Cancer Center, Richmond
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
- Local Institution - 0238, Fairfax
- Hematology Oncology Associates of Fredericksburg, Fredericksburg
- Blue Ridge Cancer Care, Roanoke
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/20更新 · NCT06911502SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Charlottesville
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。